search:

ONCOLOGY: Trabectedin For The Treatment Of Relapsed Ovarian Cancer

From: Hope Waltman (anonymous@obgyn.net)
Sat, 22 Nov 2008 06:50:07 -0600 (CST)


Ortho Biotech Announces NDA Submission For Trabectedin For The Treatment Of Relapsed Ovarian Cancer

"Ortho Biotech Products, L.P. announced the submission of a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for trabectedin when administered in combination with DOXIL(R) (doxorubicin HCI liposome injection)for the treatment of women with relapsed ovarian cancer (ROC). If approved, trabectedin combined with DOXIL will provide a new, non-platinum treatment option for these patients in the United States. http://www.medicalnewstoday.com/articles/130233.php "

Regards, Hope Waltman, WHF Moderator http://www.hopeforfibroids.org




recommended search...
Google
OBGYN.net forums endometriosis zone Web

use when must restrict search to only the women's health forum...
Enter search keywords:
Returns per screen: Require all keywords:
Return to [ Women's Health Forum ] Report TECHNICAL Problems ONLY to: webmaster@obgyn.net
Last Updated: Wed Dec 2 06:56:19 2009

Women's Insurance Checklist from Auto Insurance Quote

home | medical professionals | women | industry | forums | international
e-mail | about us | advertising | our sponsors | contact us | disclaimer |

This information is provided for educational purposes only.
Please read the disclaimer. ©1996-2008, all rights reserved.
Do not reproduce without permission of MediSpecialty.com